The Journal of Nutrition Vol. 127 No. 5 May 1997, pp. 717-723
Copyright ©1997 by the American Society for Nutritional Sciences

Acarbose Enhances Human Colonic Butyrate Production

Manuscript received 15 July 1996. Initial reviews completed 30 July 1996. Revision accepted 14 January 1997.

Gary A. Weaver^{*, ,} , Colette T. Tangel^*, Jean A. Krause^*, Margaret M. Parfitt^*, Paul L. Jenkins^*, Joanne M. Rader^*, Bertha A. Lewis^**, Terry L. Miller, and Meyer J. Wolin

^* The Mary Imogene Bassett Research Institute and  Department of Medicine, The Mary Imogene Bassett Hospital, Cooperstown, NY 13326; ^** Cornell University, Ithaca, NY 14853; and  Wadsworth Center NYS Department of Health, Albany, NY 12201

Earlier studies suggest that butyrate has colonic differentiating and nutritional effects and that acarbose increases butyrate production. To determine the effects of acarbose on colonic fermentation, subjects were given 50-200 mg acarbose or placebo (cornstarch), three times per day, with meals in a double-blind crossover study. Fecal concentrations of starch and starch-fermenting bacteria were measured and fecal fermentation products determined after incubation of fecal suspensions with and without added substrate for 6 and 24 h. Substrate additions were cornstarch, cornstarch plus acarbose and potato starch. Dietary starch consumption was similar during acarbose and placebo treatment periods, but fecal starch concentrations were found to be significantly greater with acarbose treatment. Ratios of starch-fermenting to total anaerobic bacteria were also significantly greater with acarbose treatment. Butyrate in feces, measured either as concentration or as percentage of total short-chain fatty acids, was significantly greater with acarbose treatment than with placebo treatment. Butyrate ranged from 22.3 to 27.5 mol/100 mol for the 50-200 mg, three times per day doses of acarbose compared with 18.3-19.3 mol/100 mol for the comparable placebo periods. The propionate in fecal total short-chain fatty acids was significantly less with acarbose treatment (10.7-12.1 mol/100 mol) than with placebo treatment (13.7-14.2 mol/100 mol). Butyrate production was significantly greater in fermentations in samples collected during acarbose treatment, whereas production of acetate and propionate was significantly less. Fermentation decreased when acarbose was added directly to cornstarch fermentations. Acarbose effectively augmented colonic butyrate production by several mechanisms; it reduced starch absorption, expanded concentrations of starch-fermenting and butyrate-producing bacteria and inhibited starch use by acetate- and propionate-producing bacteria.

This article has been cited by other articles:

				J. W. Finley, J. B. Burrell, and P. G. Reeves Pinto Bean Consumption Changes SCFA Profiles in Fecal Fermentations, Bacterial Populations of the Lower Bowel, and Lipid Profiles in Blood of Humans J. Nutr., November 1, 2007; 137(11): 2391 - 2398. [Abstract] [Full Text] [PDF]

				M. J. Wolin, T. L. Miller, M. D. Collins, and P. A. Lawson Formate-Dependent Growth and Homoacetogenic Fermentation by a Bacterium from Human Feces: Description of Bryantella formatexigens gen. nov., sp. nov. Appl. Envir. Microbiol., October 1, 2003; 69(10): 6321 - 6326. [Abstract] [Full Text] [PDF]

				D. L. Topping and P. M. Clifton Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides Physiol Rev, July 1, 2001; 81(3): 1031 - 1064. [Abstract] [Full Text] [PDF]

				G. A. Weaver, C. T. Tangel, J. A. Krause, M. M. Parfitt, J. J. Stragand, P. L. Jenkins, T. A. Erb, R. H. Davidson, H. D. Alpern, W. B. Guiney Jr., et al. Biomarkers of Human Colonic Cell Growth Are Influenced Differently by a History of Colonic Neoplasia and the Consumption of Acarbose J. Nutr., November 1, 2000; 130(11): 2718 - 2725. [Abstract] [Full Text] [PDF]

				E J Simpson, M A S Chapman, J Dawson, D Berry, I A Macdonald, and A Cole In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis Gut, January 1, 2000; 46(1): 73 - 77. [Abstract] [Full Text] [PDF]

				M. J. Wolin, T. L. Miller, S. Yerry, Y. Zhang, S. Bank, and G. A. Weaver Changes of Fermentation Pathways of Fecal Microbial Communities Associated with a Drug Treatment That Increases Dietary Starch in the Human Colon Appl. Envir. Microbiol., July 1, 1999; 65(7): 2807 - 2812. [Abstract] [Full Text]